Investorideas.com newswire, breaking biotechnology and pharma news

Friday, September 24, 2010

Biotech News: UV Flu Technologies (OTCBB: UVFT) Air Purification System Airing on “The Designing Spaces/ Holiday Spaces” TV Show

Biotech News: UV Flu Technologies (OTCBB: UVFT) Air Purification System Airing on “The Designing Spaces/ Holiday Spaces” TV Show



Show expects to reach up to 75 million households

CENTERVILLE, MA – (Investorideas.com Newswire ) – September 24, 2010) – Biotechnology Products company , UV Flu Technologies, Inc. (OTCBB: UVFT) reports the company's UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.


“We are thrilled to be working with Designing Spaces as part of this Holiday Show,” said Jack Lennon, President of UV Flu Technologies. “The theme of the segment will be how to stay healthy indoors over the holidays, and our product fits perfectly within this theme. Our ViraTech UV-400, has been laboratory proven to kill airborne bacteria and other contaminants, including odors and volatile organic compounds. There are hundreds of compounds, such as formaldehyde, acetone, benzene, etc… that can be found in the average home and which can cause severe respiratory problems.”



Mr. Lennon further stated “These compounds are regularly found in furniture, cleaning supplies, building materials, insecticides, and even common household items like hairspray. With families spending over 90% of their time indoors, particularly with the proliferation of indoor home theaters and computer games, the public is susceptible to increased risks of exposure or transmission of serious illnesses during the holidays. We hope to educate people to the many dangers associated with poor indoor air quality, and that our UV-400 is a very cost-effective ways to protect themselves. We believe this show will provide a tremendous platform to reach one of our key target markets; parents concerned with the health of their families.”



Further details regarding the Company’s business, financial reports and agreements are filed as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database.



About UV Flu Technologies, Inc. (OTCBB: UVFT)

UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality (“IAQ”) industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.



Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.



ON BEHALF OF THE BOARD



UV Flu Technologies, Inc.

-----------------------------

John J. Lennon, President & CEO



Investor Information:

Geaux IR Services, Inc.

Toll-Free: 1-888-355-8838

investors@uvflutech.com



Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.


Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp



More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory

No comments:

Post a Comment